Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-009770

Chief Financial Officer gave up 10,750 shares (to pay taxes)

  • Chief Financial Officer acquired 26,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2026-02-01 Option exercise +26,000 142,915 D
Smith Hunter C Chief Financial Officer 2026-02-01 Shares withheld for taxes −10,750 $108.99 $1,171,643 132,165 D
Derivatives
Smith Hunter C Chief Financial Officer 2026-02-01 Option exercise · Restricted Stock Units −4,062 0 D
Smith Hunter C Chief Financial Officer 2026-02-01 Option exercise · Restricted Stock Units −4,925 4,925 D
Smith Hunter C Chief Financial Officer 2026-02-01 Option exercise · Restricted Stock Units −6,600 13,200 D
Smith Hunter C Chief Financial Officer 2026-02-01 Option exercise · Restricted Stock Units −10,413 31,237 D
Loading xslF345X05/tm264963-8_4seq1.xml…